These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 3032224)
1. Use of 99Tcm radionuclides to show nephrotoxicity of cyclosporin A in transplanted kidneys. Thomsen HS; Munck O Acta Radiol; 1987; 28(1):59-61. PubMed ID: 3032224 [TBL] [Abstract][Full Text] [Related]
2. Nephrotoxicity of ciclosporin in transplanted kidneys demonstrated with the 99mTc perfusion studies. Thomsen HS; Munck O Contrib Nephrol; 1987; 56():159-62. PubMed ID: 3038463 [No Abstract] [Full Text] [Related]
3. Treatment of renal transplantation rejection. Cyclosporin A versus conventional treatment with azathioprine, prednisone and antithymocyte immunoglobulin in primary cadaveric renal transplantation. Hall BM; Tiller DJ; Horvath JS; Duggin GG; Johnson JR; Roy LP; Hurley B; Harris JP; Rogers JR; Stephen MS Med J Aust; 1985 Feb; 142(3):179-85. PubMed ID: 3881654 [TBL] [Abstract][Full Text] [Related]
4. Cyclosporine, azathioprine, and prednisone as treatment for cyclosporine-induced nephrotoxicity in renal transplant recipients. Lorber MI; Flechner SM; Van Buren CT; Kerman RH; Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):282-5. PubMed ID: 3895668 [No Abstract] [Full Text] [Related]
5. In vitro stability of 99Tcm bone scan preparations from different manufacturers measured by various radiopharmaceutical parameters. Pauwels EK; Feitsma RI Nucl Med Commun; 1984 Jul; 5(7):467-72. PubMed ID: 6099535 [TBL] [Abstract][Full Text] [Related]
6. Renal biopsy morphology in renal transplantation. A comparative study of the light-microscopic appearances of biopsies from patients treated with cyclosporin A or azathioprine prednisone and antilymphocyte globulin. Farnsworth A; Hall BM; Ng AB; Duggin GG; Horvath JS; Sheil AG; Tiller DJ Am J Surg Pathol; 1984 Apr; 8(4):243-52. PubMed ID: 6369996 [TBL] [Abstract][Full Text] [Related]
7. Hypertension after renal transplantation in patients treated with cyclosporin and azathioprine. Gordjani N; Offner G; Hoyer PF; Brodehl J Arch Dis Child; 1990 Mar; 65(3):275-9. PubMed ID: 2334203 [TBL] [Abstract][Full Text] [Related]
8. Triple therapy and initial renal graft perfusion. Thomsen HS; Nielsen SL Dan Med Bull; 1988 Aug; 35(4):393-5. PubMed ID: 3048925 [TBL] [Abstract][Full Text] [Related]
9. [Kaposi's sarcoma in kidney transplant treated with cyclosporin and azathioprine]. Cózar JM; Martínez Piñeiro L; Avellana JA; de la Peña J; Hidalgo L; Sanz A; Burgos F; Martínez Piñeiro JA Arch Esp Urol; 1990 Mar; 43(2):155-8. PubMed ID: 2363579 [TBL] [Abstract][Full Text] [Related]
10. Renography and biopsy-verified acute rejection in renal allotransplanted patients receiving cyclosporin A. Thomsen HS; Nielsen SL; Larsen S; Løkkegaard H Eur J Nucl Med; 1987; 12(10):473-6. PubMed ID: 3552684 [TBL] [Abstract][Full Text] [Related]
11. Is cyclosporine A-induced nephrotoxicity in recipients of renal allografts progressive? Thiel G; Mihatsch M; Landmann J; Hermle M; Brunner FP; Harder F Transplant Proc; 1985 Aug; 17(4 Suppl 1):169-78. PubMed ID: 3895657 [No Abstract] [Full Text] [Related]
12. 'Nephrotoxicity' and metabolic acidosis in transplant patients on cyclosporin A. Hamilton DV; Evans DB; Henderson RG; Thiru S; Calne RY; White DJ; Carmichael DJ Proc Eur Dial Transplant Assoc; 1981; 18():400-9. PubMed ID: 7036160 [TBL] [Abstract][Full Text] [Related]
13. Increased frequency of posttransplant lymphomas in patients treated with cyclosporin, azathioprine, and prednisone. Smith JL; Wilkinson AH; Hunsicker LG; Tobacman J; Kapelanski DP; Johnson M; Wright FH; Behrendt DM; Corry RJ Transplant Proc; 1989 Feb; 21(1 Pt 3):3199-200. PubMed ID: 2650451 [No Abstract] [Full Text] [Related]
14. Histological lesions associated with cyclosporin: incidence and reversibility in one year old kidney transplants. Versluis DJ; Ten Kate FJ; Wenting GJ; Jeekel J; Weimar W J Clin Pathol; 1988 May; 41(5):498-503. PubMed ID: 3290264 [TBL] [Abstract][Full Text] [Related]
15. The case against conversion to azathioprine in cyclosporine-treated renal recipients. Flechner SM; Lorber M; Van Buren C; Kerman R; Kahan BD Transplant Proc; 1985 Aug; 17(4 Suppl 1):276-81. PubMed ID: 3895667 [No Abstract] [Full Text] [Related]
16. The influence of immunosuppression on the prevalence of aseptic bone necrosis after renal transplantation. Cotorruelo JG; De Francisco AL; Canga E; Amado JA; Riancho JA; De Bonis E; Zubimendi JA; Ruiz JC; Sanz de Castro S; Arias M Transplant Proc; 1991 Aug; 23(4):2199-200. PubMed ID: 1871842 [No Abstract] [Full Text] [Related]
17. Magnetic resonance imaging of renal transplants: its value in the differentiation of acute rejection and cyclosporin A nephrotoxicity. te Strake L; Schultze Kool LJ; Paul LC; Tegzess AM; Weening JJ; Hermans J; Doornbos J; Bluemm RG; Bloem JL Clin Radiol; 1988 May; 39(3):220-8. PubMed ID: 3293883 [TBL] [Abstract][Full Text] [Related]
18. Pancreatic endocrine function in patients treated with ciclosporine, azathioprine and prednisone after kidney transplantation. Zukowska-Szczechowska E; Grzeszczak W; Kokot F; Nieszporek T; Kuśmierski S; Kurzbauer R; Szkodny A Acta Med Pol; 1988; 29(1-2):53-64. PubMed ID: 3076741 [No Abstract] [Full Text] [Related]